Literature DB >> 7987156

Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.

R Collins1, C Baigent, P Sandercock, R Peto.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 7987156      PMCID： PMC2541706          DOI： 10.1136/bmj.309.6963.1215

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  17 in total

1.  Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews.

Authors:  R Collins; R Gray; J Godwin; R Peto
Journal:  Stat Med       Date:  1987 Apr-May       Impact factor: 2.373

2.  Why do we need systematic overviews of randomized trials?

Authors:  R Peto
Journal:  Stat Med       Date:  1987 Apr-May       Impact factor: 2.373

3.  Sex, aspirin, and venous thrombosis.

Authors:  M Hume; W R Donaldson; J Suprenant
Journal:  Orthop Clin North Am       Date:  1978-07       Impact factor: 2.472

4.  Deep venous thrombosis: a continuing problem.

Authors:  J H Scurr; P D Coleridge-Smith; J H Hasty
Journal:  BMJ       Date:  1988-07-02

Review 5.  Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.

Authors:  R Collins; A Scrimgeour; S Yusuf; R Peto
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

6.  Acetylsalicylic acid in a trial to diminish thromboembolic complications after elective hip surgery.

Authors:  J Soreff; H Johnsson; L Diener; L Göransson
Journal:  Acta Orthop Scand       Date:  1975-05

7.  Combined administration of low dose heparin and aspirin as prophylaxis of deep vein thrombosis after hip joint surgery.

Authors:  T H Schöndorf; D Hey
Journal:  Haemostasis       Date:  1976

8.  Prevention of venous thromboembolism by administration of hydroxychloroquine. A preliminary report.

Authors:  O D Chrisman; G A Snook; T C Wilson; J Y Short
Journal:  J Bone Joint Surg Am       Date:  1976-10       Impact factor: 5.284

9.  Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial.

Authors: 
Journal:  Lancet       Date:  1975-07-12       Impact factor: 79.321

10.  Alpha 1-antitrypsin Pi-types in 965 COPD patients.

Authors:  J Lieberman; B Winter; A Sastre
Journal:  Chest       Date:  1986-03       Impact factor: 9.410
View more
  12 in total

Review 1.  Preventing thromboembolic complications in older orthopaedic surgery patients: interventions and outcomes.

Authors:  J W Eikelboom; J S Ginsberg
Journal:  Drugs Aging       Date:  1999-10       Impact factor: 3.923

2.  Cyclooxygenase products and atherosclerosis.

Authors:  Macrae F Linton; Sergio Fazio
Journal:  Drug Discov Today Ther Strateg       Date:  2008

3.  Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice.

Authors:  D Praticò; C Tillmann; Z B Zhang; H Li; G A FitzGerald
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

Review 4.  Aspirin and clopidogrel for prevention of ischemic stroke.

Authors:  Ruth M Thomson; David C Anderson
Journal:  Curr Neurol Neurosci Rep       Date:  2013-02       Impact factor: 5.081

5.  Platelets are dominant contributors to hypercoagulability after injury.

Authors:  Jeffrey N Harr; Ernest E Moore; Theresa L Chin; Arsen Ghasabyan; Eduardo Gonzalez; Max V Wohlauer; Anirban Banerjee; Christopher C Silliman; Angela Sauaia
Journal:  J Trauma Acute Care Surg       Date:  2013-03       Impact factor: 3.313

6.  Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer Recurrence.

Authors:  Deirdre P Cronin-Fenton; Uffe Heide-Jørgensen; Thomas P Ahern; Timothy L Lash; Peer Christiansen; Bent Ejlertsen; Henrik T Sørensen
Journal:  Epidemiology       Date:  2016-07       Impact factor: 4.822

Review 7.  Peripheral arterial occlusive disease: magnetic resonance imaging and the role of aggressive medical management.

Authors:  Alan B Lumsden; Terry W Rice; Changyi Chen; Wei Zhou; Peter H Lin; Paul Bray; Joel Morrisett; Vijay Nambi; Christie Ballantyne
Journal:  World J Surg       Date:  2007-04       Impact factor: 3.352

Review 8.  Promiscuous drugs compared to selective drugs (promiscuity can be a virtue).

Authors:  Simon K Mencher; Long G Wang
Journal:  BMC Clin Pharmacol       Date:  2005-04-26

9.  Systemic inflammatory response syndrome and platelet count ≥250×10(9) are associated with venous thromboembolic disease.

Authors:  Amy Pate; Gerard A Baltazar; Shahniwaz Labana; Trishul Bhagat; Joseph Kim; Akella Chendrasekhar
Journal:  Int J Gen Med       Date:  2015-01-14

10.  Evaluation of GW406381 for treatment of osteoarthritis of the knee: two randomized, controlled studies.

Authors:  Diane J Boswell; Keld Ostergaard; Richard S Philipson; Rachel A Hodge; David Blum; Judith C Brown; Steve N Quessy
Journal:  Medscape J Med       Date:  2008-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.